FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 175 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $46,000 | -66.9% | 1,226 | -84.4% | 0.00% | – |
Q4 2020 | $139,000 | +2216.7% | 7,861 | +535.0% | 0.00% | – |
Q3 2020 | $6,000 | -57.1% | 1,238 | -43.8% | 0.00% | – |
Q2 2020 | $14,000 | -26.3% | 2,203 | -48.0% | 0.00% | – |
Q4 2019 | $19,000 | +58.3% | 4,238 | +40.2% | 0.00% | – |
Q3 2019 | $12,000 | -29.4% | 3,023 | +5.8% | 0.00% | – |
Q2 2019 | $17,000 | +54.5% | 2,858 | +129.0% | 0.00% | – |
Q4 2018 | $11,000 | +266.7% | 1,248 | +426.6% | 0.00% | – |
Q3 2018 | $3,000 | -87.5% | 237 | -84.5% | 0.00% | – |
Q2 2018 | $24,000 | +20.0% | 1,525 | +29.9% | 0.00% | – |
Q1 2018 | $20,000 | +150.0% | 1,174 | +189.9% | 0.00% | – |
Q4 2017 | $8,000 | -20.0% | 405 | +63.3% | 0.00% | – |
Q3 2017 | $10,000 | +42.9% | 248 | +1.6% | 0.00% | – |
Q2 2017 | $7,000 | -99.2% | 244 | -99.0% | 0.00% | -100.0% |
Q1 2017 | $904,000 | -37.6% | 25,000 | -0.7% | 0.00% | -50.0% |
Q4 2016 | $1,448,000 | +9.9% | 25,176 | +0.3% | 0.00% | +100.0% |
Q3 2016 | $1,317,000 | +26.9% | 25,101 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $1,038,000 | +103700.0% | 25,101 | +139350.0% | 0.00% | – |
Q1 2016 | $1,000 | -99.3% | 18 | -99.5% | 0.00% | – |
Q4 2015 | $142,000 | – | 3,415 | +28358.3% | 0.00% | – |
Q3 2015 | $0 | -100.0% | 12 | -100.0% | 0.00% | -100.0% |
Q2 2015 | $8,476,000 | +46988.9% | 341,210 | +29063.2% | 0.01% | – |
Q2 2014 | $18,000 | -10.0% | 1,170 | +17.0% | 0.00% | – |
Q1 2014 | $20,000 | +17.6% | 1,000 | 0.0% | 0.00% | – |
Q4 2013 | $17,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|